228 related articles for article (PubMed ID: 30540177)
1. Structure-Based Survey of the Binding Modes of BACE1 Inhibitors.
Hu H; Chen Z; Xu X; Xu Y
ACS Chem Neurosci; 2019 Feb; 10(2):880-889. PubMed ID: 30540177
[TBL] [Abstract][Full Text] [Related]
2. Computational analysis of BACE1-ligand complex crystal structures and linear discriminant analysis for identification of BACE1 inhibitors with anti P-glycoprotein binding property.
Manoharan P; Chennoju K; Ghoshal N
J Biomol Struct Dyn; 2018 Jan; 36(1):262-276. PubMed ID: 28081663
[TBL] [Abstract][Full Text] [Related]
3. Discovery of furo[2,3-d][1,3]thiazinamines as beta amyloid cleaving enzyme-1 (BACE1) inhibitors.
Wu YJ; Guernon J; Rajamani R; Toyn JH; Ahlijanian MK; Albright CF; Muckelbauer J; Chang C; Camac D; Macor JE; Thompson LA
Bioorg Med Chem Lett; 2016 Dec; 26(23):5729-5731. PubMed ID: 27816517
[TBL] [Abstract][Full Text] [Related]
4. Conformational dynamics of cathepsin D and binding to a small-molecule BACE1 inhibitor.
Ellis CR; Tsai CC; Lin FY; Shen J
J Comput Chem; 2017 Jun; 38(15):1260-1269. PubMed ID: 28370344
[TBL] [Abstract][Full Text] [Related]
5. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study.
Ahmad SS; Akhtar S; Danish Rizvi SM; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM
Curr Comput Aided Drug Des; 2017 Nov; 13(4):311-318. PubMed ID: 28413992
[TBL] [Abstract][Full Text] [Related]
6. Computational modelling of potent β-secretase (BACE1) inhibitors towards Alzheimer's disease treatment.
Ugbaja SC; Sanusi ZK; Appiah-Kubi P; Lawal MM; Kumalo HM
Biophys Chem; 2021 Mar; 270():106536. PubMed ID: 33387910
[TBL] [Abstract][Full Text] [Related]
7. Fragment-based designing for the generation of novel leads against BACE1.
Das S; Chakraborty S; Basu S
Cent Nerv Syst Agents Med Chem; 2015; 15(1):52-64. PubMed ID: 25625854
[TBL] [Abstract][Full Text] [Related]
8. A PM7 dynamic residue-ligand interactions energy landscape of the BACE1 inhibitory pathway by hydroxyethylamine compounds. Part I: The flap closure process.
Gueto-Tettay C; Martinez-Consuegra A; Zuchniarz J; Gueto-Tettay LR; Drosos-Ramírez JC
J Mol Graph Model; 2017 Sep; 76():274-288. PubMed ID: 28746905
[TBL] [Abstract][Full Text] [Related]
9. Conformational transition in the substrate binding domain of β-secretase exploited by NMA and its implication in inhibitor recognition: BACE1-myricetin a case study.
Chakraborty S; Kumar S; Basu S
Neurochem Int; 2011 Jul; 58(8):914-23. PubMed ID: 21354237
[TBL] [Abstract][Full Text] [Related]
10. Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer's Disease.
Read J; Suphioglu C
Cell Physiol Biochem; 2019; 53(2):413-428. PubMed ID: 31415717
[TBL] [Abstract][Full Text] [Related]
11. BACE1 as a therapeutic target in Alzheimer's disease: rationale and current status.
Evin G; Hince C
Drugs Aging; 2013 Oct; 30(10):755-64. PubMed ID: 23842796
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
[TBL] [Abstract][Full Text] [Related]
13. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
14. Pyridinyl aminohydantoins as small molecule BACE1 inhibitors.
Zhou P; Li Y; Fan Y; Wang Z; Chopra R; Olland A; Hu Y; Magolda RL; Pangalos M; Reinhart PH; Turner MJ; Bard J; Malamas MS; Robichaud AJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2326-9. PubMed ID: 20202842
[TBL] [Abstract][Full Text] [Related]
15. BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease.
Barão S; Moechars D; Lichtenthaler SF; De Strooper B
Trends Neurosci; 2016 Mar; 39(3):158-169. PubMed ID: 26833257
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2.
Fujimoto K; Yoshida S; Tadano G; Asada N; Fuchino K; Suzuki S; Matsuoka E; Yamamoto T; Yamamoto S; Ando S; Kanegawa N; Tonomura Y; Ito H; Moechars D; Rombouts FJR; Gijsen HJM; Kusakabe KI
J Med Chem; 2021 Mar; 64(6):3075-3085. PubMed ID: 33719429
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story.
Stamford A; Strickland C
Curr Opin Chem Biol; 2013 Jun; 17(3):320-8. PubMed ID: 23683349
[TBL] [Abstract][Full Text] [Related]
18. Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraints.
Winneroski LL; Erickson JA; Green SJ; Lopez JE; Stout SL; Porter WJ; Timm DE; Audia JE; Barberis M; Beck JP; Boggs LN; Borders AR; Boyer RD; Brier RA; Hembre EJ; Hendle J; Garcia-Losada P; Minguez JM; Mathes BM; May PC; Monk SA; Rankovic Z; Shi Y; Watson BM; Yang Z; Mergott DJ
Bioorg Med Chem; 2020 Jan; 28(1):115194. PubMed ID: 31786008
[TBL] [Abstract][Full Text] [Related]
19. BACE1 inhibitors: a head group scan on a series of amides.
Woltering TJ; Wostl W; Hilpert H; Rogers-Evans M; Pinard E; Mayweg A; Göbel M; Banner DW; Benz J; Travagli M; Pollastrini M; Marconi G; Gabellieri E; Guba W; Mauser H; Andreini M; Jacobsen H; Power E; Narquizian R
Bioorg Med Chem Lett; 2013 Jul; 23(14):4239-43. PubMed ID: 23735744
[TBL] [Abstract][Full Text] [Related]
20. Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels.
Youn K; Yu Y; Lee J; Jeong WS; Ho CT; Jun M
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28869548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
